SMITHS FALLS, ON, May 20, 2016 /CNW/ - Canopy Growth Corporation
("Canopy Growth") recently issued a press release outlining a
partnership with AusCann Group Holdings Ltd. ("AusCann"), whereby
Canopy Growth would obtain certain equity holdings in AusCann, in
exchange for its consultation in a number of areas including
production, quality assurance and operations, and strategic
advisory services.
Canopy Growth would like to clarify that all such expertise and
advisory services offered or performed by Canopy Growth
subsidiaries will be exclusively carried out by Tweed Inc. and
Tweed Farms Inc. Procedures, expertise, and/or intellectual
property under license from Bedrocan BV as to medicinal cannabis
(flos) and so employed by Bedrocan Canada or any affiliates of
Canopy Growth will not be shared or form the basis for any
cooperation, consultation or other form of consulting provided
under the terms of the partnership with AusCann. Canopy Growth
and its affiliates are exclusively entitled to utilize any of its
rights under the Bedrocan BV license for Canada and South-America only.
Here's to future (clarified) growth.
About Canopy Growth Corporation
Canopy Growth is
Canada's first publicly traded
medical marijuana company and the first geographically diversified
producer with multiple licenses under the Marihuana for Medical
Purposes Regulations. Through its wholly owned subsidiaries, Tweed,
Tweed Farms, and Bedrocan Canada, the Company operates three
state-of-the-art production facilities in Ontario and distributes marijuana across the
country to Canadian patients managing a host of medical conditions.
The Company is dedicated to educating healthcare practitioners,
providing consistent access to high quality medication, conducting
robust clinical research, and furthering the public's understanding
of how marijuana is used for medical purposes.
www.canopygrowth.com
SOURCE Canopy Growth Corporation